Phase I dose-escalation study of cyclophosphamide combined with bortezomib and dexamethasone in Japanese patients with relapsed and/or refractory multiple myeloma
Crossref DOI link: https://doi.org/10.1007/s12185-015-1846-5
Published Online: 2015-08-23
Published Print: 2015-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sugiura, Isamu
Terabe, Satomi
Kinoshita, Tomohiro
Yamamoto, Kazuhito
Sawa, Masashi
Ozawa, Yukiyasu
Atsuta, Yoshiko
Suzuki, Ritsuro
Shimizu, Kazuyuki
Text and Data Mining valid from 2015-08-23